Dr David Spivey, MD | |
2912 Maplewood Ave, Winston-salem, NC 27103-1507 | |
(336) 760-0706 | |
(336) 760-1927 |
Full Name | Dr David Spivey |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2912 Maplewood Ave, Winston-salem, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275510570 | NPI | - | NPPES |
139JW | Other | NC | BLUE CROSS BLUE SHIELD |
5900809 | Medicaid | NC | |
DP0069 | Other | RR MEDICARE - GROUP PTAN | |
P00722602 | Other | RR MEDICARE - PROVIDER PTAN | |
7695691 | Other | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 30582 (North Carolina) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | 30582 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Spivey, MD 2912 Maplewood Ave, Winston-salem, NC 27103-1507 Ph: (336) 760-0706 | Dr David Spivey, MD 2912 Maplewood Ave, Winston-salem, NC 27103-1507 Ph: (336) 760-0706 |
News Archive
The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT), today announced that Lowry Computer, a leading systems integrator and Motorola channel partner, has deployed its 802.11n wireless LAN (WLAN) solution at Memorial Medical Center (MMC) of Western Michigan, a community hospital located in Ludington, Mich.
This is a joint press release of Hiru Corporation (HIRU) and Hard to Treat Diseases (HTDS) - The two companies are pleased to announce the finalization and completion of the purchase and sale of the MindUp BioResearch Division. Details of the transaction completed on cash and stock basis can be found at the Pink Sheets web site www.pinksheets.com under the "filings" tab.
CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company's common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
Researchers at Washington University in St. Louis have developed algorithms to identify weak spots in tendons, muscles and bones prone to tearing or breaking.
› Verified 8 days ago